Cell proliferation, measured as flow cytometric S‐phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population‐based study

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0412|1-6349|10|1064-1073

ISSN： 0001-6349

Source： ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol.1-6349, Iss.10, 2015-10, pp. : 1064-1073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell proliferation, measured as flow cytometric S‐phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population‐based study

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 10, 2015-10 ,pp. : 1064-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma

By  

HISTOPATHOLOGY, Vol. 64, Iss. 3, 2014-02 ,pp. : 389-398

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advanced-Stage (FIGO III–IV) Epithelial Ovarian Cancer: Multivariate Analysis of Prognostic Factors in an Area without a Tertiary Referral Oncology Center. A Population-Based Study

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 406-410

Karger

Access to resources Recommend Favorite

Thirty‐day postoperative mortality for endometrial carcinoma in England: a population‐based study

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 123, Iss. 11, 2016-10 ,pp. : 1853-1861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study

By  

Oncology, Vol. 81, Iss. 2, 2011-10 ,pp. : 104-112

Karger

Access to resources Recommend Favorite